Telomeric function of mammalian telomerases at short telomeres

Journal of Cell Science

Volumn 123, Issue 10, 2010, Pages 1693-1704

  Fakhoury, Johans ^a,b   Marie Egyptienne, Delphine Tamara ^c   Londoño Vallejo, José Arturo ^d   Autexier, Chantal ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d INSTITUT CURIE   (France)

Author keywords

ALT; Telomerase activity; Telomerase processivity; Telomere maintenance

Indexed keywords

TELOMERASE; DNA; TERT PROTEIN, HUMAN; TERT PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CHROMOSOME; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TELOMERE; ANIMAL; BIOSYNTHESIS; ENZYME SPECIFICITY; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR CLONING; PATHOLOGY; PROTEIN MULTIMERIZATION; SPECIES DIFFERENCE; TRANSGENE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CLONING, MOLECULAR; DNA; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MICE; PROTEIN MULTIMERIZATION; SPECIES SPECIFICITY; SUBSTRATE SPECIFICITY; TELOMERASE; TELOMERE; TRANSGENES;

MAMMALIA;

EID: 77952415874     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.063636     Document Type: Article

References (70)

1. Armbruster, B. N., Banik, S. S., Guo, C., Smith, A. C. and Counter, C. M. (2001). N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo. Mol. Cell. Biol. 21, 7775-7786.
2. Armbruster, B. N., Etheridge, K. T., Broccoli, D. and Counter, C. M. (2003). Putative telomere-recruiting domain in the catalytic subunit of human telomerase. Mol. Cell. Biol. 23, 3237-3246.
3. Autexier, C. and Greider, C. W. (1995). Boundary elements of the Tetrahymena telomerase RNA template and alignment domains. Genes Dev. 15, 2227-2239.
4. Autexier, C. and Lue, N. F. (2006). The structure and function of telomerase reverse transcriptase. Annu. Rev. Biochem. 75, 493-517. (Pubitemid 44118041)
5. Autexier, C., Pruzan, R., Funk, W. D. and Greider, C. W. (1996). Reconstitution of human telomerase activity and identification of a minimal functional region of the human telomerase RNA. EMBO J. 15, 5928-5935.
6. Banik, S. S., Guo, C., Smith, A. C., Margolis, S. S., Richardson, D. A., Tirado, C. A. and Counter, C. M. (2002). C-terminal regions of the human telomerase catalytic subunit essential for in vivo enzyme activity. Mol. Cell. Biol. 22, 6234-6246.
7. Beattie, T. L., Zhou, W., Robinson, M. O. and Harrington, L. (1998). Reconstitution of human telomerase activity in vitro. Curr. Biol. 8, 177-180. (Pubitemid 28091578)
8. Beattie, T. L., Zhou, W., Robinson, M. O. and Harrington, L. (2000). Polymerization defects within human telomerase are distinct from telomerase RNA and TEP1 binding. Mol. Biol. Cell 11, 3329-3340.
9. Blasco, M., Funk, W., Villeponteau, B. and Greider, C. W. (1995). Functional characterization and developmental regulation of mouse telomerase RNA. Science 269, 1267-1270.
10. Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A. and Greider, C. W. (1997). Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34.
11. Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S. and Wright, W. E. (1998). Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352. (Pubitemid 28063364)
12. Boehm, J. S., Hession, M. T., Bulmer, S. E. and Hahn, W. C. (2005). Transformation of human and murine fibroblasts without viral oncoproteins. Mol. Cell. Biol. 25, 6464-6474.
13. Cerone, M. A., Londono-Vallejo, J. A. and Bacchetti, S. (2001). Telomere maintenance by telomerase and by recombination can coexist in human cells. Hum. Mol. Genet. 10, 1945-1952.
14. Cerone, M. A., Londono-Vallejo, J. A. and Autexier, C. (2006). Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance. Oncogene 25, 7411-7420.
15. Chen, J. L. and Greider, C. W. (2003). Determinants in mammalian telomerase RNA that mediate enzyme processivity and cross-species incompatibility. EMBO J. 22, 304-314.
16. Cohen, S. B., Graham, M. E., Lovrecz, G. O., Bache, N., Robinson, P. J. and Reddel, R. R. (2007). Protein composition of catalytically active human telomerase from immortal cells. Science 315, 1850-1853.
17. Counter, C. M., Hahn, W. C., Wei, W., Dickinson Caddle, S., Beijersbergen, R. L., Lansdorp, P. M., Sedivy, J. M. and Weinberg, R. A. (1998a). Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc. Natl. Acad. Sci. USA 95, 14723-14728.
18. Counter, C. M., Meyerson, M., Eaton, E. N., Ellisen, L. W., Dickinson Caddle, S., Haber, D. A. and Weinberg, R. A. (1998b). Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 16, 1217-1222. (Pubitemid 28127521)
19. Cristofari, G., Sikora, K. and Lingner, J. (2007). Telomerase unplugged. ACS Chem. Biol. 2, 155-158.
20. Dikmen, Z. G., Gellert, G. C., Jackson, S., Gryaznov, S., Tressler, R., Dogan, P., Wright, W. E. and Shay, J. W. (2005). In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor. Cancer Res. 65, 7866-7873.
21. Draskovic, I., Arnoult, N., Steiner, V., Bacchetti, S., Lomonte, P. and Londono-Vallejo, A. (2009). Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination. Proc. Natl. Acad. Sci. USA 106, 15726-15731.
22. Dunham, M. A., Neumann, A. A., Fasching, C. L. and Reddel, R. R. (2000). Telomere maintenance by recombination in human cells. Nat. Genet. 26, 447-450.
23. Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J. et al. (1995). The human telomerase RNA component. Science 269, 1236-1241.
24. Fu, D. and Collins, K. (2003). Distinct biogenesis pathways for human telomerase RNA and H/ACA small nucleolar RNAs. Mol. Cell 11, 1361-1372. (Pubitemid 36645153)
25. Garforth, S. J., Wu, Y. Y. and Prasad, V. R. (2006). Structural features of mouse telomerase RNA are responsible for the lower activity of mouse telomerase versus human telomerase. Biochem. J. 397, 399-406.
26. Gavory, G., Farrow, M. and Balasubramanian, S. (2002). Minimum length requirement of the alignment domain of human telomerase RNA to sustain catalytic activity in vitro. Nucleic Acids Res. 30, 4470-4480.
27. Greenberg, R. A., Allsopp, R. C., Chin, L., Morin, G. B. and DePinho, R. A. (1998). Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16, 1723-1730.
28. Greider, C. W. and Blackburn, E. H. (1989). A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337, 331-337.
29. Grobelny, J. V., Kulp-McEliece, M. and Broccoli, D. (2001). Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway. Hum. Mol. Genet. 10, 1953-1961.
30. Guiducci, C., Cerone, M. A. and Bacchetti, S. (2001). Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability. Oncogene 20, 714-725. (Pubitemid 32179340)
31. Harley, C. B. (2008). Telomerase and cancer therapeutics. Nat. Rev. Cancer 8, 167-179.
32. Hemann, M. T., Strong, M. A., Hao, L.-Y. and Greider, C. W. (2001). The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107, 67-77.
33. Huard, S. and Autexier, C. (2004). Human telomerase catalyzes nucleolytic primer cleavage. Nucleic Acids Res. 32, 2171-2180.
34. Huard, S., Moriarty, T. J. and Autexier, C. (2003). The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity. Nucleic Acids Res. 31, 4059-4070. (Pubitemid 37442286)
35. Itahana, K., Campisi, J. and Dimri, G. (2004). Mechanisms of cellular senescence in human and mouse cells. Biogerontology 5, 1-10.
36. Kim, N. W. and Wu, F. (1997). Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res. 25, 2595-2597.
37. Kipling, D. (1997). Telomere structure and telomerase expression during mouse development and tumorigenesis. Eur. J. Cancer 33, 792-800.
38. Liu, Y., Snow, B. E., Hande, M. P., Yeung, D., Erdmann, N. J., Wakeham, A., Itie, A., Siderovski, D. P., Lansdorp, P. M., Robinson, M. O. et al. (2000). The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr. Biol. 10, 1459-1462.
39. Liu, Y., Kha, H., Ungrin, M., Robinson, M. O. and Harrington, L. (2002). Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert. Proc. Natl. Acad. Sci. USA 99, 3597-3602. (Pubitemid 34252152)
40. Marie-Egyptienne, D. T., Cerone, M. A., Londono-Vallejo, J. A. and Autexier, C. (2005). A human-Tetrahymena pseudoknot chimeric telomerase RNA reconstitutes a nonprocessive enzyme in vitro that is defective in telomere elongation. Nucleic Acids Res. 33, 5446-5457.
41. Marie-Egyptienne, D. T., Brault, M. E., Zhu, S. and Autexier, C. (2008). Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation. Exp. Cell Res. 314, 668-675.
42. Martin-Rivera, L. and Blasco, M. (2001). Identification of functional domains and dominant negative mutations in vertebrate telomerase RNA using an in vivo reconstitution system. J. Biol. Chem. 276, 5856-5865.
43. Martin-Rivera, L., Herrera, E., Albar, J. P. and Blasco, M. A. (1998). Expression of mouse telomerase catalytic subunit in embryos and adult tissues. Proc. Natl. Acad. Sci. USA 95, 10471-10476. (Pubitemid 28413091)
44. Middleman, E. J., Choi, J., Venteicher, A. S., Cheung, P. and Artandi, S. E. (2006). Regulation of cellular immortalization and steady-state levels of the telomerase reverse transcriptase through its carboxy-terminal domain. Mol. Cell. Biol. 26, 2146-2159.
45. Mitchell, J. and Collins, K. (2000). Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase. Mol. Cell 6, 361-371.
46. Moriarty, T. J., Huard, S., Dupuis, S. and Autexier, C. (2002). Functional multimerization of human telomerase requires an RNA interaction domain in the N terminus of the catalytic subunit. Mol. Cell. Biol. 22, 1253-1265.
47. Moriarty, T. J., Marie-Egyptienne, D. T. and Autexier, C. (2004). Functional organization of repeat addition processivity and DNA synthesis determinants in the human telomerase multimer. Mol. Cell. Biol. 24, 3720-3733.
48. Moriarty, T. J., Ward, R. J., Taboski, M. A. and Autexier, C. (2005). An anchor site-type defect in human telomerase that disrupts telomere length maintenance and cellular immortalization. Mol. Biol. Cell 16, 3152-3161.
49. Morin, G. B. (1989). The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59, 521-529.
50. Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B. and Cech, T. R. (1997). Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-959.
51. Palm, W. and de Lange, T. (2008). How shelterin protects mammalian telomeres. Annu. Rev. Genet. 42, 301-334.
52. Perrem, K., Colgin, L. M., Neumann, A. A., Yeager, T. R. and Reddel, R. R. (2001). Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol. Cell. Biol. 21, 3862-3875.
53. Prowse, K. R., Avilion, A. A. and Greider, C. W. (1993). Identification of a nonprocessive telomerase activity from mouse cells. Proc. Natl. Acad. Sci. USA 90, 1493-1497.
54. Sachsinger, J., Gonzalez-Suarez, E., Samper, E., Heicappell, R., Muller, M. and Blasco, M. A. (2001). Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells. Cancer Res. 61, 5580-5586.
55. Scheel, C., Schaefer, K. L., Jauch, A., Keller, M., Wai, D., Brinkschmidt, C., van Valen, F., Boecker, W., Dockhorn-Dworniczak, B. and Poremba, C. (2001). Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas. Oncogene 20, 3835-3844. (Pubitemid 32646194)
56. Seimiya, H., Sawada, H., Muramatsu, Y., Shimizu, M., Ohko, K., Yamane, K. and Tsuruo, T. (2000). Involvement of 14-3-3 proteins in nuclear localization of telomerase. EMBO J. 19, 2652-2661.
57. Snow, B. E., Erdmann, N., Cruickshank, J., Goldman, H., Gill, R. M., Robinson, M. O. and Harrington, L. (2003). Functional conservation of the telomerase protein Est1p in humans. Curr. Biol. 13, 698-704.
58. Snow, B. E., Mateyak, M., Paderova, J., Wakeham, A., Iorio, C., Zakian, V., Squire, J. and Harrington, L. (2007). Murine Pif1 interacts with telomerase and is dispensable for telomere function in vivo. Mol. Cell. Biol. 27, 1017-1026.
59. Teixeira, M. T., Arneric, M., Sperisen, P. and Lingner, J. (2004). Telomere length homeostasis is achieved via a switch between telomerase-extendible and -nonextendible states. Cell 117, 323-335. (Pubitemid 38534539)
60. Tomlinson, R. L., Ziegler, T. D., Supakorndej, T., Terns, R. M. and Terns, M. P. (2006). Cell cycle-regulated trafficking of human telomerase to telomeres. Mol. Biol. Cell 17, 955-965.
61. Tomlinson, R. L., Abreu, E. B., Ziegler, T., Ly, H., Counter, C. M., Terns, R. M. and Terns, M. P. (2008). Telomerase reverse transcriptase is required for the localization of telomerase RNA to cajal bodies and telomeres in human cancer cells. Mol. Biol. Cell 19, 3793-3800.
62. Vaziri, H. and Benchimol, S. (1998). Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8, 279-282.
63. Wang, E. S., Wu, K., Chin, A. C., Chen-Kiang, S., Pongracz, K., Gryaznov, S. and Moore, M. A. S. (2004). Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma. Blood 103, 258-266.
64. Wang, F., Podell, E. R., Zaug, A. J., Yang, Y., Baciu, P., Cech, T. R. and Lei, M. (2007). The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature 445, 506-510.
65. Wen, J., Cong, Y. and Bacchetti, S. (1998). Reconstitution of wild-type or mutant telomerase activity in telomerase-negative immortal human cells. Hum. Mol. Genet. 7, 1137-1141.
66. Wyatt, H. D., Lobb, D. A. and Beattie, T. L. (2007). Characterization of physical and functional anchor site interactions in human telomerase. Mol. Cell. Biol. 27, 3226-3240.
67. Xin, H., Liu, D., Wan, M., Safari, A., Kim, H., Sun, W., O'Connor, M. S. and Songyang, Z. (2007). TPP1 is a homologue of ciliate TEBP-[beta] and interacts with POT1 to recruit telomerase. Nature 445, 559-562.
68. Zhang, D.-H., Zhou, B., Huang, Y., Xu, L.-X. and Zhou, J.-Q. (2006). The human Pif1 helicase, a potential Escherichia coli RecD homologue, inhibits telomerase activity. Nucleic Acids Res. 34, 1393-1404.
69. Zhou, X. Z. and Lu, K. P. (2001). The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell 107, 347-359.
70. Zhu, Y., Tomlinson, R. L., Lukowiak, A. A., Terns, R. M. and Terns, M. P. (2004). Telomerase RNA accumulates in Cajal bodies in human cancer cells. Mol. Biol. Cell 15, 81-90.